Christina Magkoufopoulou

Comparison of HepG2 and HepaRG by Whole-Genome Gene Expression Analysis for the Purpose of Chemical Hazard Identification

Danyel Jennen, Christina Magkoufopoulou, Hans B. Ketelslegers et al. · Toxicological Sciences · 2010 · 218 citations · Full text

Pharmacy, Molecular Biology, Toxicology +10

A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo

Christina Magkoufopoulou, Sandra M.H. Claessen, Maria Tsamou et al. · Carcinogenesis · 2012 · 87 citations · Full text

Pharmacy, Toxicology, Hepatotoxicology +16

Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells

Christina Magkoufopoulou, Sandra M.H. Claessen, Danyel Jennen et al. · Mutagenesis · 2011 · 52 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells

Danyel Jennen, Ainhoa Ruiz‐Aracama, Christina Magkoufopoulou et al. · BMC Systems Biology · 2011 · 46 citations · Full text

Pharmacy, Biochemistry, Toxicology +17

Performance of in vitro γH2AX assay in HepG2 cells to predict in vivo genotoxicity

Maria Tsamou, Danyel Jennen, Sandra M.H. Claessen et al. · Mutagenesis · 2012 · 42 citations · Full text

Pharmacy, Molecular Biology, Toxicology +17